Status: Not yet recruiting
Assessment of QSant™ for Underlying Allograft Rejection
The AQUA registry is a multi-center observational study to assess the clinical management of kidney transplant recipients (KTRs) with use of the QSant test. QSant is a test based on 6 urinary biomarkers including cell-free DNA, that is used for the evaluation and management of acute rejection in renal allograft recipients with clinical suspicion of rejection, as well as subclinical rejection.
Participants needed: 4,000
Trial details
Biological sex: AllType: ObservationalSponsor: NephroSantUpdated: Sep 28, 2022Duration: 24 Months
Eligibility criteria
Kidney transplant recipient, ≤ 90 days post kidney transplant of any age, solita... [+2]
Inability to provide a voided urine sample per collection protocol [+1]